Skip to main content

Table 4 Estimated cases of cervical cancer, cervical cancer deaths, cervical intraepithelial neoplasia grade 1 (CIN 1), grade 2 (CIN 2), grade 3 (CIN 3) and genital warts cases per 100 000 women who are screened, or vaccinated and screened over a lifetime

From: Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis

 

Cervical cancer cases

Deaths from cervical cancer

CIN 3 cases detected

CIN 2 cases detected

CIN 1 cases detected

Genital warts cases

Screening only

715

218

5325

3906

12453

7147

Screening and vaccination

297

91

2846

2223

9899

2349

Case avoided

418

127

2479

1683

2554

4798

  1. * 85% vaccine coverage rate and lifetime duration of vaccine efficacy